TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
RYTM

Rhythm Pharmaceuticals Inc

Healthcare · Biotechnology

92.50$ -0.4% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Rhythm Pharmaceuticals Inc (RYTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 437 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RYTM
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 12 26 41 35 152 139 292 278 260 237 211 178 309 274 243 215 187 422 388 356 330 285 278 390 382 346 310 354 333 259 382 364 392 387 373 507 480 442 437
– 11 25 39 32 151 138 291 277 259 230 204 171 302 268 238 210 182 412 378 336 308 253 249 362 354 318 284 329 308 236 357 340 374 369 361 495 467 430 427
– 6.5 12 29 28 34 43 210 58 50 42 63 72 62 56 59 68 101 87 69 92 59 79 113 185 128 110 116 65 60 53 162 48 89 106 136 52 54 62 66
– 11 24 38 30 148 136 288 272 252 222 195 162 292 257 229 202 173 405 368 328 295 241 236 348 333 295 254 299 276 201 319 298 321 314 291 416 389 341 331
– – – – – – – – – – – – – – – – – – – – – 1.0 0.9 1.7 3.3 6.2 8.1 14 15 15 15 18 19 19 18 26 33 26 34 40
– – – – 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – 0.1 0.1 1.7 1.6 2.9 5.5 6.2 7.8 8.6 8.5 12 14 19 19 19 22 26 29 31
– 0.9 0.9 0.8 0.8 0.8 0.8 0.7 0.9 1.1 5.9 7.0 6.0 5.7 5.5 5.3 3.3 3.2 3.0 4.7 3.0 2.8 2.7 2.6 2.4 2.2 2.0 1.8 – – – – – – – – – – – –
– – – – 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – 5.0 4.9 4.8 4.7 8.5 8.3 8.1 7.9 7.7 7.5 7.2 7.0 6.8 6.6 6.4 6.2 6.0 5.7 5.5 5.3 5.1 4.9
– 5.0 4.2 5.1 5.7 6.9 5.8 7.4 8.1 14 16 29 28 28 21 18 19 21 41 37 34 45 49 82 108 118 126 128 157 163 197 202 211 228 224 239 211 210 205 220
– 4.7 4.2 4.8 5.5 6.7 5.6 7.2 7.8 14 13 26 25 24 18 15 16 18 17 17 23 43 47 45 33 40 46 46 50 55 54 55 98 116 112 129 104 106 103 124
– – – – – – – – – – 0.2 0.4 0.5 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.7 0.7 0.8 0.8 0.8 – – 0.2 0.5 0.6 0.7 0.7 0.7
– 1.9 1.5 1.3 2.3 2.4 2.5 3.3 0.2 7.6 4.0 6.6 7.7 10 5.9 4.8 3.8 4.9 9.1 5.0 4.6 5.7 12 6.0 4.9 4.8 13 8.4 3.8 4.9 7.6 4.5 4.9 12 12 16 14 14 12 16
– – – – 0.0 0.0 0.0 0.0 0.0 – 3.4 – – – – – – – – – – – – 36 74 1.3 1.3 1.3 – – – – – – – – – – – –
– 7.3 22 36 29 145 134 284 270 246 220 181 149 281 253 226 197 167 381 352 322 284 236 196 281 264 220 182 197 170 62 179 153 165 163 134 296 270 238 217
– -77 -83 -90 -100 -110 -127 -141 -159 -185 -214 -256 -292 -325 -359 -391 -424 -459 -416 -451 -486 -529 -582 -627 -668 -710 -762 -809 -853 -895 -1,036 -1,068 -1,112 -1,155 -1,205 -1,251 -1,304 -1,352 -1,408 -1,457
17 17 17 26 26 26 27 28 34 34 34 34 35 42 44 44 44 44 49 50 50 50 50 50 51 56 57 57 58 59 60 61 61 62 63 64 64 67 68 69

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?